XTX Topco Ltd

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1828301 LONDON, X0

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$202,095

+$17,257 QoQ

Shares Held

19,395

-35.5% QoQ

Ownership

0.064%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 95 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $414,894,447 across 381 Biotechnology names. RNAC ranks #235 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,522	$19,031,687
2	ASND	Ascendis Pharma A/S	43,289	$11,546,042
3	BBIO	BridgeBio Pharma, Inc.	116,611	$8,685,187
4	MRNA	Moderna, Inc.	123,281	$8,633,368
5	JAZZ	Jazz Pharmaceuticals plc	30,496	$7,348,621
6	KYMR	Kymera Therapeutics, Inc.	61,501	$7,052,319
7	CYTK	Cytokinetics Inc	80,743	$6,878,496
8	PTCT	Ptc Therapeutics, Inc.	81,923	$6,682,459

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$202,095	19,395	-35.5%	Shares	Defined	2026-08-14
2026-03-31	$184,838	30,055	+193.6%	Shares	Defined	2026-05-15
2025-12-31	$73,815	10,238	-61.0%	Shares	Defined	2026-02-17
2025-09-30	$268,366	26,259	-26.8%	Shares	Defined	2025-11-14
2023-12-31	$24,705	35,857	-57.8%	Shares	Defined	2024-02-13
2023-09-30	$90,089	84,990	-42.7%	Shares	Defined	2023-11-13
2023-06-30	$166,031	148,242	-20.6%	Shares	Defined	2023-08-14
2022-12-31	$211,054	186,774	-2.6%	Shares	Defined	2023-02-14
2022-09-30	$314,415	191,717	+157.6%	Shares	Defined	2022-11-14
2022-06-30	$97,488	74,419	-38.8%	Shares	Defined	2022-08-15
2022-03-31	$149,585	121,614	+261.9%	Shares	Defined	2022-05-13
2021-12-31	$109,535	33,600	+5.3%	Shares	Defined	2022-02-11
2021-06-30	$133,354	31,903	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.